Effectiveness of craniotomy and long- term survival in 35 patients with gestational trophoblastic neoplasia with brain metastases: a clinical retrospective analysis

다국어 초록 (Multilingual Abstract)

Objective: To investigate the clinical characteristics, treatments, and prognostic factors among patients with gestational trophoblastic neoplasia (GTN) exhibiting brain metastases who underwent craniotomy.
Methods: Thirty-five patients with GTN who had brain metastases and subsequently underwent craniotomies between January 1990 and December 2018 at Peking Union Medical College Hospital were identified using the GTN database. Their clinical manifestations, treatments, outcomes, and prognostic factors were retrospectively analyzed.
Results: All 35 patients underwent decompressive craniotomy, hematoma removal, and metastatic tumor resection combined with multiagent chemotherapy. Eighty percent (28/35) achieved complete remission, 11.4% (4/35) achieved partial remission, and 8.6% (3/35) had progressive disease. Not counting 2 patients who were lost to follow-up, 81.8% of the patients (27/33) were alive after a median follow-up of 72 months. The 5-year overall survival rate was 80.4%. Univariate analysis revealed that a history of chemotherapy failure (p=0.020) and a >1-week interval between craniotomy and chemotherapy commencement (p=0.027) were adverse risk factors for survival. Multivariate analysis showed that previous chemotherapy failure remained an independent risk factor for poor survival (odds ratio=11.50; 95% confidence interval=1.55–85.15; p=0.017).
Conclusion: Decompressive craniotomy is a life-saving option if metastatic hemorrhage and intracranial hypertension produce a risk of cerebral hernia in patients with GTN who have brain metastases. Higher survival rates and improved prognoses can be achieved through perioperative multidisciplinary cooperation and timely standard postoperative chemotherapy.

참고문헌 (Reference)

1 Ngan HY, "Update on the diagnosis and management of gestational trophoblastic disease" 143 (143): 79-85, 2018

2 Semple PL, "The role of neurosurgery in the treatment of cerebral metastases from choriocarcinoma : a report of two cases" 14 : 157-161, 2004

3 Feng F, "Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine(FAEV)for patients with relapsed/chemoresistant gestational trophoblastic neoplasia" 22 : 1588-1594, 2011

4 Yang J, "Primary treatment of stage IV gestational trophoblastic neoplasia with floxuridine, dactinomycin, etoposide and vincristine(FAEV) : A report based on our 10-year clinical experiences" 143 : 68-72, 2016

5 Xiao C, "Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia : a 24-year experience in Peking union medical college hospital" 15 : 318-, 2015

6 Suresh TN, "Intracranial haemorrhage resulting from unsuspected choriocarcinoma metastasis" 49 : 231-236, 2001

7 Soper JT, "High-risk gestational trophoblastic neoplasia with brain metastases : individualized multidisciplinary therapy in the management of four patients" 104 : 691-694, 2007

8 Ngan HY, "Gestational trophoblastic neoplasia, FIGO 2000 staging and classification" 83 (83): 175-177, 2003

9 Gavanier D, "Gestational trophoblastic neoplasia with brain metastasis at initial presentation : a retrospective study" 24 : 153-160, 2019

10 Evans AC Jr, "Gestational trophoblastic disease metastatic to the central nervous system" 59 : 226-230, 1995

11 Neubauer NL, "Fatal gestational trophoblastic neoplasia : an analysis of treatment failures at the Brewer Trophoblastic Disease Center from 1979–2012 compared to 1962–1978" 138 : 339-342, 2015

12 Ghaemmaghami F, "Evaluation and management of brain metastatic patients with high-risk gestational trophoblastic tumors" 14 : 966-971, 2004

13 Yang JJ, "Emergency craniotomy in patients with intracranial metastatic gestational trophoblastic tumor" 89 : 35-38, 2005

14 Alifrangis C, "EMA/CO for high-risk gestational trophoblastic neoplasia : good outcomes with induction low-dose etoposide-cisplatin and genetic analysis" 31 : 280-286, 2013

15 Lybol C, "Comparing cisplatinbased combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia" 49 : 860-867, 2013

16 Deng L, "Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour" (1) : CD005196-, 2013

17 Kong Y, "Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients : a retrospective cohort study" 146 : 81-86, 2017

18 Altintaş A, "Central nervous system involvement in gestational trophoblastic neoplasia" 22 : 154-156, 2001

19 Neubauer NL, "Brain metastasis in gestational trophoblastic neoplasia : an update" 57 : 288-292, 2012

20 Bakri Y, "Brain metastases of gestational trophoblastic tumor" 39 : 179-184, 1994

21 Savage P, "Brain metastases in gestational trophoblast neoplasia : an update on incidence, management and outcome" 137 : 73-76, 2015

22 Piura E, "Brain metastases from gestational trophoblastic neoplasia : review of pertinent literature" 35 : 359-367, 2014